Consensus EPS · Q2 2026
$0.95
Consensus revenue · Q2 2026
$5.4B
Analysts
12
Expected report
Jul 31, 2026
What to watch
- Analyst ratings: Mixed
Analyst consensus
Based on estimates from 12 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $5.3B | $5.4B | $5.5B |
| EPS | $0.91 | $0.95 | $0.97 |
| EBITDA | $1.1B | $1.1B | $1.1B |
| EBIT | $901.4M | $909.9M | $921.8M |
| Net income | $730.5M | $762.6M | $778.7M |
- Revenue$5.4B
- EPS$0.95
- EBITDA$1.1B
- EBIT$909.9M
- Net income$762.6M
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q1 2026 | $5.3B | $5.2B | +2.1% | $0.97 | $0.94 | +2.8% |
| Q4 2025 | $5.2B | $5.1B | +2.1% | $0.95 | $0.91 | +4.2% |
- Q1 2026+2.1%+2.8%
- Q4 2025+2.1%+4.2%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Colgate-Palmolive (CL) Q2 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 1 analyst.
- Low
- $79.00
- Consensus
- $96.30
- Median
- $99.50
- High
- $102.00
- Current
- $91.63
- Upside
- +5.1%
Upside calculated vs most recent trading price of $91.63.
Analyst ratings
Consensus: Hold — based on 45 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 21, 2026 | Barclays | maintain | Equal Weight | Equal Weight |
| Jul 16, 2026 | UBS | maintain | Buy | Buy |
| Jul 16, 2026 | JP Morgan | maintain | Overweight | Overweight |
| Jul 14, 2026 | Citigroup | maintain | Buy | Buy |
| Jul 9, 2026 | Piper Sandler | maintain | Overweight | Overweight |
| Jul 8, 2026 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| May 5, 2026 | Barclays | maintain | Equal Weight | Equal Weight |
| May 4, 2026 | UBS | maintain | Buy | Buy |
| May 4, 2026 | RBC Capital | maintain | Outperform | Outperform |
| May 4, 2026 | JP Morgan | maintain | Overweight | Overweight |
- Jul 21, 2026BarclaysEqual Weight
- Jul 16, 2026UBSBuy
- Jul 16, 2026JP MorganOverweight
- Jul 14, 2026CitigroupBuy
- Jul 9, 2026Piper SandlerOverweight
- Jul 8, 2026Wells FargoEqual Weight
- May 5, 2026BarclaysEqual Weight
- May 4, 2026UBSBuy
- May 4, 2026RBC CapitalOutperform
- May 4, 2026JP MorganOverweight
Frequently asked questions
Colgate-Palmolive (CL) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks1.80% TTM
- Dividend Profile2.29% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History5 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.